Mikrobiol. Z. 2019; 81(5):114-140. Russian.
doi: https://doi.org/10.15407/microbiolj81.05.114

Current State of the Problem of Probiotic Preparations

Safronova L.A., Iliash V.M.

Zabolotny Institute of Microbiology and Virology, NAS of Ukraine
154 Akad. Zabolotny Str., Kyiv, 03143, Ukraine

This review summarizes the literature data on modern approaches to probiotic preparations, their role in preventing disturbances and restoration of human and animal microbiota, and also about the complex effect on health. The international requirements to probiotic strains and preparations on their basis are given. Positive effects of probiotics on an organism are considered, mechanisms of action of preparations are described. The characteristic of a number of the known probiotics created on the basis of microorganisms of different taxonomic groups is presented.

Keywords: probiotic preparations, microorganisms, microbiota, intestinal dysbacteriosis, mechanism of action.

Full text (PDF, in Russian)

  1. Gracheva NM, Bondarenko VM. Probioticheskiye preparaty v terapii i profilaktike disbakterioza kishechnika. Infektsionnyye bolezni. 2004; 2(2):53–8. Russian.
  2. Zeng MY, Cisalpino D, Varadarajan S, Hellman J, Warren HS, et al. Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens. Immunity. 2016; 44:647–58. https://doi.org/10.1016/j.immuni.2016.02.006
  3. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012; 336:1268–1273. https://doi.org/10.1126/science.1223490
  4. Dorrestein PC, Mazmanian SK, Knight R. Finding the missing links among metabolites, microbes and the host. Immunity. 2014; 40:824–32. https://doi.org/10.1016/j.immuni.2014.05.015
  5. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN. Role of the normal gut microbiota. World J Gastroenterol. 2015; 21(29):8787–803. https://doi.org/10.3748/wjg.v21.i29.8787
  6. Iebba V, Totino V, Gagliardi A, Santangelo F, Cacciotti F, et al. Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiol. 2016; 39(1):1–12.
  7. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015; 26:26191. https://doi.org/10.3402/mehd.v26.26191
  8. Lilley DM, Stillwell RH. Probiotics: growth promoting factors produced by microorganisms. Science. 1965; 147:747–748. https://doi.org/10.1126/science.147.3659.747
  9. Food and Agriculture Organization of the United Nations/World Health Organization FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Joint FAO / WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food; London, Ontario, Canada: 2002.
  10. Hill C, Guarner F, Reid G. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11:506–14. https://doi.org/10.1038/nrgastro.2014.66
  11. Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017; 9(9):1021. https://doi.org/10.3390/nu9091021
  12. Sorokulova I. Modern Status and Perspectives of Bacillus Bacteria as Probiotics. J Prob Health. 2013; (4):1000–106. https://doi.org/10.4172/2329-8901.1000e106
  13. Vsemirnaya Gastroenterologicheskaya associaciya: prakticheskie rekomendacii. Probiotiki i prebiotiki, 2017. http://www.worldgastroenterology.org/UserFiles/.../probiotics-and-prebiotics-russian-2017.p.
  14. Sánchez B, Delgado S, Blanco-Míguez A, Lourenço A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res. 2017; 61(1). https://doi.org/10.1002/mnfr.201600240
  15. Safronova LA, Zelena LB, Klochko VV, Reva ON. Does the applicability of Bacillus strains in probiotics rely upon their taxonomy? Can. J. Microbiol. 2012; 58(2):212–19. https://doi.org/10.1139/w11-113
  16. Zielińska D, Ołdak A, Rzepkowska A, Zieliński K. Advances in Biotechnology for Food Industry. Handbook of Food Bioengineering Academic Press 2018: 167–96. https://doi.org/10.1016/B978-0-12-811443-8.00006-2
  17. Fijan S. Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature. Int J Environ Res Public Health. 2014; 11(5):4745–67. https://doi.org/10.3390/ijerph110504745
  18. Ngo TH, Baccigalupi L, Huxham A. Characterization of Bacillus Species Used for Oral Bacteriotherapy and Bacterioprophylaxis of Gastrointestinal Disorders. Applied and Environmental Microbiology. 2000; 66(12):5241–47. https://doi.org/10.1128/AEM.66.12.5241-5247.2000
  19. Sanders M, Morelli L, Tompkins T. Sporeformers as Human Probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Comprehensive Reviews in Food Science and Food Safety. 2003; 2:101-10. https://doi.org/10.1111/j.1541-4337.2003.tb00017.x
  20. Doron S, Snydman DR. Risk and Safety of Probiotics. Clin Infect Dis. 2015; 60(2):129–34. https://doi.org/10.1093/cid/civ085
  21. European Food Safety Authority (EFSA). Scientific Opinion on the update the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA. EFSA J. 2017; 15:1–177. https://doi.org/10.2903/j.efsa.2017.4884
  22. Snydman DR. The safety of probiotics. Clin Infect Dis. 2008; 46(2):104-11. https://doi.org/10.1086/523331
  23. Sorokulova I. Preclinical Testing in the Development of Probiotics: Regulatory Perspective with Bacillus Strains as an Example. Clin. Infect. Diseases. 2008; 46:92–5. https://doi.org/10.1086/523334
  24. Doaa Safwat Mohammad. On the Role of Genomic Islands in Bacterial Pathogenicity and Antimicrobial Resistance. International Journal of Advanced Biotechnology and Bioengineering. 2014; 2(1):18–36.
  25. Suvorov A.N., Zaharenko S.M., Alehina G.G. Enterokokki kak probiotiki vybora. Klin pitanie. 2003; 1:26–9. Russian.
  26. Togay SÖ, Keskin AÇ, Açık L, Temiz A. Virulence genes, antibiotic resistance and plasmid profiles of Enterococcus faecalis and Enterococcus faecium from naturally fermented Turkish foods. J Appl Microbiol. 2010; 109:1084–92. https://doi.org/10.1111/j.1365-2672.2010.04763.x
  27. Imperial IC, Ibana JA. Addressing the Antibiotic Resistance Problem with Probiotics: Reducing the Risk of Its Double-Edged Sword Effect. Front Microbiol. 2016; 7: 1983.
  28. Gevers D, Huys G, Swings J. In vitro conjugal transfer of tetracycline resistance from Lactobacillus isolates to other Gram-positive bacteria. FEMS Microbiol Lett. 2003; 225:125–30. https://doi.org/10.1016/S0378-1097(03)00505-6
  29. Courvalin P. Antibiotic resistance: the pros and cons of probiotics. Dig Liver Dis. 2006; 38(Suppl 2):261–5. https://doi.org/10.1016/S1590-8658(07)60006-1
  30. Launay A, Ballard SA, Johnson PDR, Grayson ML, Lambert T. Transfer of Vancomycin Resistance Transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the Gut of Gnotobiotic Mice. Antimicrobial Agents and Chemotherapy. 2006; 50(3):1054–62. https://doi.org/10.1128/AAC.50.3.1054-1062.2006
  31. Bubnov RV, Babenko LP, Lazarenko LM, Mokrozub VV, Spivak MY. Specific properties of probiotic strains: relevance and benefits for the host. EPMA J. 2018; 13; 9(2):205-223. https://doi.org/10.1007/s13167-018-0132-z
  32. Garcia-Gonzalez N, Prete R, Battista N, Corsetti A. Adhesion Properties of Food-Associated Lactobacillus plantarum Strains on Human Intestinal Epithelial Cells and Modulation of IL-8 Release. Front Microbiol. 2018; 9:2392. https://doi.org/10.3389/fmicb.2018.02392
  33. Biancone L, Vavassori P, Monteleone I. Cytoskeletal proteins and resident flora. Digestive and Liver Disease 2002; 34(2):34–6. https://doi.org/10.1016/S1590-8658(02)80161-X
  34. Nishiyama K, Sugiyama M, Mukai T. Adhesion Properties of Lactic Acid Bacteria on Intestinal Mucin. Kitazawa H, Villena J, eds. Microorganisms. 2016; 4(3):34. https://doi.org/10.3390/microorganisms4030034
  35. Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, Isolauri E. Adherence of Probiotic Bacteria to Human Intestinal Mucus in Healthy Infants and during Rotavirus Infection. Clinical and Diagnostic Laboratory Immunology. 2001; 8(2):293–6. https://doi.org/10.1128/CDLI.8.2.293-296.2001
  36. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic Mechanisms of Action. Ann Nutr Metab 2012; 61:160-74. https://doi.org/10.1159/000342079
  37. Siciliano RA, Mazzeo MF. Molecular mechanisms of probiotic action: a proteomic perspective. Curr Opin Microbiol. 2012; 15(3):390–6. https://doi.org/10.1016/j.mib.2012.03.006
  38. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol. 2007; 23:679–92. https://doi.org/10.1097/MOG.0b013e3282f0cffc
  39. Llewellyn A, Foey A. Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events. Nutrients. 2017; 9(10):1156. https://doi.org/10.3390/nu9101156
  40. Giorgetti GM, Brandimarte G, Fabiocchi F, Ricci S, Flamini P, et al. Interactions between Innate Immunity, Microbiota, and Probiotics. J Immunol Res. 2015; 2015:1–7. https://doi.org/10.1155/2015/501361
  41. Lebeer S, Vanderleyde J, De Keersmaecker SCJ. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nature Reviews Microbiology. 2010; 8:171–84. https://doi.org/10.1038/nrmicro2297
  42. Tripathi MK, Giri SK. Probiotic functional foods: Survival of probiotics during processing and storage. Journal of Functional Foods. 2014; 9:225–41. https://doi.org/10.1016/j.jff.2014.04.030
  43. Chávarri M, Marañó n I, Villarán MC. Encapsulation Technology to Protect Probiotic Bacteria, Probiotics, Everlon Cid Rigobelo, IntechOpen. 2012. https://doi.org/10.5772/50046
  44. Kailasapathy K. Encapsulation technologies for functional foods and nutraceutical product development. CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources. 2009; 4(33):1–19. https://doi.org/10.1079/PAVSNNR20094033
  45. Mokhtari S, Jafari SM, Khomeiri M. Survival of encapsulated probiotics in pasteurized grape juice and evaluation of their properties during storage. Food Sci Technol Int. 2019; 25(2):120–9. https://doi.org/10.1177/1082013218801113
  46. Cutting SM. Bacillus probiotics. Food Microbiol. 2011; 28:214–20. https://doi.org/10.1016/j.fm.2010.03.007
  47. Kalinichenko SV, Korotkyx OO, Tishhenko IYu. Suchasni napryamky stvorennya ta udoskonalennya probiotykiv. Ukr. biofarmacevtychny j. 2016; 1(42):4–10. Ukrainian.
  48. Yankovskij DS, Moiseenko RA, Dyment GS. Mesto disbioza v patologii cheloveka. Sovrem pediatriya. 2010; 29(1):154-64. Russian.
  49. Ursova NI, Rimarchuk GV. Problema disbakterioza v pediatricheskoj praktike. Pediatriya. Bolezni pishevarit sistemy. 2007; 1:71–5. Russian.
  50. Ouwehand AC, Invernici MM, Furlaneto FAC, Messora MR. Effectiveness of Multistrain Versus Single-strain Probiotics: Current Status and Recommendations for the Future. J Clin Gastroenterol. 2018; 52(1); Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10-12, 2017:35–40. https://doi.org/10.1097/MCG.0000000000001052
  51. Osipova IG. Eksperimentalno-klinicheskoe izuchenie sporovyh probiotikov: avtoref. dis. doktora biol. nauk. 03.00.07 - Mikrobiologiya. Moscow; 2006. Russian.
  52. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr. 1995; 125(6):1401–12. https://doi.org/10.1093/jn/125.6.1401
  53. Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G, et al. Prebiotics: why definitions matter. Curr Opin Biotechnol. 2016; 37:1–7. https://doi.org/10.1016/j.copbio.2015.09.001
  54. Carlson JL, Erickson JM, Lloyd BL,Slavin JL. Health Effects and Sources of Prebiotic Dietary Fiber. Cur Dev in Nutr. 2018; 2(3):nzy005.
  55. Guarner F, Sanders ME, Eliakim R, et al. Probiotics and prebiotics. WGO Practice Guideline. 2017; 1–35.
  56. Bondarenko VM., Gracheva NM. Preparaty probiotiki, prebiotiki i sinbiotiki v terapii i profilaktike kishechnyh disbakteriozov. Farmateka. 2003; 7:56–63. Russian.
  57. Ardatskaya MD, Belmer SV, Dobritsa VP, Zaharenko SM, Lazebnik LB, et al. Disbioz (disbakterioz) kishechnika: sovremennoe sostoyanie problemyi, kompleksnaya diagnostika i lechebnaya korrektsiya Eksperimentalnaya i klinicheskaya gastroenterologiya. 2015; 117(5):13–50. Russian.
  58. Doron S, Gorbach SL. Probiotics: Their role in the treatment and prevention of disease. Expert Rev. Anti-Infect Ther. 2006; 4:261–75. https://doi.org/10.1586/14787210.4.2.261
  59. Yang Wang, Yanping Wu, Yuanyuan Wang, Han Xu, Xiaoqiang Mei, et al. Antioxidant Properties of Probiotic Bacteria. Nutrients. 2017; 9(5):521. https://doi.org/10.3390/nu9050521
  60. Safronova L, Iliash V. Biosynthetic activity of Bacilli, determining their probiotic effect. Mikrobiol Z. 2017; 79(6):120–36. Russian.
  61. Yan Zhang, Lixiang Li, Chuanguo Guo, Dan Mu, Bingcheng Feng, et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016; 16:62. https://doi.org/10.1186/s12876-016-0470-z
  62. Rostami FM, Mousavi H, Mousavi MRN, Shahsafi M. Efficacy of Probiotics in Prevention and Treatment of Infectious Diseases. Clinical Microbiology Newsletter, 2018; 40(12):97–103. https://doi.org/10.1016/j.clinmicnews.2018.06.001
  63. Potebnya GP, Safronova LA, Cheremshenko NL. Vplyv probiotyka subalinu na protepuhlynnu efektivnist vakcyny. Mikrobiol Z. 2006; 68(6):51–8. Ukrainian.
  64. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 2011; 6(3):261–74. https://doi.org/10.1007/s12263-011-0218-x
  65. Yan F., Polk DB. Probiotics and immune health. Curr Opin Gastroenterol. 2011; 27(6):496–501. https://doi.org/10.1097/MOG.0b013e32834baa4d
  66. Bubnov RV, Spivak MY, Lazarenko LM, Bomba A, Boyko NV. Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA J. 2015; 14; 6(1):14. https://doi.org/10.1186/s13167-015-0036-0
  67. Fedorak RN. Understanding why probiotic therapies can be effective in treating IBD. J of Clinical Gastroenterology. 2008; 42(3):111–5. https://doi.org/10.1097/MCG.0b013e31816d922c
  68. Chassaing B, Kumar M, Baker MT, Singh V, Vijay-Kumar M. Mammalian Gut Immunity. Biomed J. 2014; 37(5):246–58. https://doi.org/10.4103/2319-4170.130922
  69. Rocha-Ramírez LM, Pérez-Solano RA, Castañón-Alonso SL, Moreno Guerrero SS, Ramírez Pacheco A, et al. Probiotic Lactobacillus Strains Stimulate the Inflammatory Response and Activate Human Macrophages. J Immunol Res. 2017; 2017:46074-91. https://doi.org/10.1155/2017/4607491
  70. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001; 74(6):833–9. https://doi.org/10.1093/ajcn/74.6.833
  71. Horoshilova NV. Immunomoduliruyushee i lechebnoe dejstvie probiotikov. Immunologiya. 2003; 6:352–6. Russian.
  72. von der Weid T, Bulliard C, Schiffrin EJ. Induction by a Lactic Acid Bacterium of a Population of CD4+ T Cells with Low Proliferative Capacity That Produce Transforming Growth Factor β and Interleukin-10. Clinical and Diagnostic Laboratory Immunology. 2001; 8(4):695–701.
  73. Alam NH, Ashraf H. Treatment of infectious diarrhea in children. Pediatr Drugs. 2003; 5:151–65. https://doi.org/10.2165/00128072-200305030-00002
  74. Savvo VM. Lechenie disbakterioza u detej s primeneniem preparata Enterol-250. VIII kongress pediatrov Rossii «Detskaya gastroenterologiya: nastoyashee i budushee» : materialy. Moscow; 2002. p. 254. Russian.
  75. Volosovec AP, Krivopustov SP, Berezhnoj VV. Profilakticheskie i terapevticheskie aspekty klinicheskogo primeneniya Saccharomyces boulardii v sovremennoj pediatrii: dokazatelnaya baza. Zdorove rebenka. 2008; 2(11):48–53. Russian.
  76. Bludova NG. Laktobakterii, probiotiki i immunnaya sistema kishechnika. Suchasna gastroenterologiya. 2005; 4:115–20. Russian.
  77. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003; 361:1869–71. https://doi.org/10.1016/S0140-6736(03)13490-3
  78. Cox MJ, Huang YJ, Fujimura KE. Lactobacillus casei Abundance Is Associated with Profound Shifts in the Infant Gut Microbiome. Bell T, ed. PLoS ONE. 2010; 5(1):e8745. https://doi.org/10.1371/journal.pone.0008745
  79. Kalliomaki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition. 2008; 87(3):534–8. https://doi.org/10.1093/ajcn/87.3.534
  80. Rutten NB, Besseling-Van der Vaart I, Klein M, De Roock S, Vlieger AM, et al. In vitro assessment of the immunomodulatory effects of multispecies probiotic formulations for management of allergic diseases. Benef Microbes 2011; 2(3):183–92. https://doi.org/10.3920/BM2011.0012
  81. Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, et al. Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis. World J Gastroenterol. 2018; 24(1):139–49. https://doi.org/10.3748/wjg.v24.i1.139
  82. Kuznecova MA. Sostoyanie tolstoj kishki u detej s allergicheskimi zabolevaniyami: avtoref. dis. kand. med. nauk. 14.00.36 - Allergologiya i immunologiya. Moscow; 2003. Russian.
  83. Hudson L, Dermott C, Stewart P, Hudson W, et al. Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System. PLoS One. 2016; 11(4):e0153351. https://doi.org/10.1371/journal.pone.0153351
  84. King S, Tancredi D, Lenoir-Wijnkoop I, Gould K, Vann H, et al. Does probiotic consumption reduce antibiotic utilization for common acute infections? A systematic review and meta-analysis. Eur J Public Health. 2018. https://doi.org/10.1093/eurpub/cky185
  85. Fleming-Dutra KE, Hersh AL, Shapiro DJ. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA 2016; 315:1864–73. https://doi.org/10.1001/jama.2016.4151
  86. Redman MG, Ward EJ, Phillips RS. The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol. 2014; 25:1919–29. https://doi.org/10.1093/annonc/mdu106
  87. Shida K, Nomoto K. Probiotics as efficient immunopotentiators: Translational role in cancer prevention. The Indian Journal of Medical Research. 2013; 138(5):808–14.
  88. Bbosa GS, Mwebaza N, Odda J, Kyegombe DB, Ntale M. Antibiotics/antibacterial drug use, their marketing and promotion during the post-antibiotic golden age and their role in emergence of bacterial resistance. Health. 2014; 6:410–25. https://doi.org/10.4236/health.2014.65059
  89. Petrova NA. Mikroflora zheludochno-kishechnogo trakta i vozmozhnosti ee korrekcii probiotikami u bolnyh gemoblastozami: avtoref. dis. kand. biol. nauk. 03.00.07 - Mikrobiologiya. Moscow; 2002. Russian.
  90. Konishi H, Fujiya M, Tanaka H, Ueno N, Moriichi K, Sasajima J, et al. Probioticderived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis Nat Commun. 2016; 7:12365. https://doi.org/10.1038/ncomms12365
  91. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol. 2015; 21(10):3072–84. https://doi.org/10.3748/wjg.v21.i10.3072
  92. Oak SJ, Jha R. The effects of probiotics in lactose intolerance: A systematic review. Crit Rev Food Sci Nutr. 2018; 9:1–9.
  93. Vitali B, Ndagijimana M, Cruciani F, et al. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiology. 2010; 10:4. https://doi.org/10.1186/1471-2180-10-4
  94. Chow KM, Liu ZC, Prakash S, Chang TM. Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal. Artif Cells Blood Substit Biotechnol. 2003; 31(4):425–434. https://doi.org/10.1081/BIO-120025412
  95. Pastuhova VA, Zaytseva OV, Ardatskaya MD. Effektivnost Hilaka forte pri korrektsii mikroekologicheskih narusheniy v kishechnike u detey s atopicheskim dermatitom. Farmateka. 2007; 6:82–7. Russian.
  96. Ploskireva AA, Pogorelova EA. Taktika terapii pri ostryih kishechnyih infektsiyah u detey. Lechaschiy vrach. 2015; 6:24–30. Russian.
  97. Mazankova LN., Lykova EA. Probiotiki: harakteristika preparatov i vybor v pediatricheskoj praktike. Det infekcii. 2004; 1:18–23. Russian.
  98. Bondarenko VM, Vorobev AA. Disbiozy i preparaty s probioticheskoj funkciej. Zhurn mikrobiologii. 2004; 1:84–92. Russian.
  99. Liskovich VV, Naumov IA, Ganchar YeP, Dembovskaya SV. Assessment of lacidofilwm efficiency in vaginal dysbiosis and antibiotics associated diarrhea prevention in puerperas after cesarean sections. Zdravohranenie, 2010; 1:63–6.
  100. Hong HA, Duc LH, Cutting SM. The use of bacterial spore formers as probiotics. FEMS Microbiol Rev. 2005; 29:813–35. https://doi.org/10.1016/j.femsre.2004.12.001
  101. Elshaghabee FM, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives. Front Microbiol. 2017; 8:490. https://doi.org/10.3389/fmicb.2017.01490
  102. Ushakova NA, Voznesenskaya VV, Kozlova AA Vydelenie somatostatin-podobnogo peptida kletkami V-8130, kishechnogo simbionta dikoj pticy Tetrao urogallus i vliyanie bacilly na zhivotnyj organizm. Dokl AN. 2010; 434(2):282–5. Russian. https://doi.org/10.1134/S0012496610050108
  103. Bozdogan B, Galopin S, Gerbaud G. Chromosomalaad D2 encodes an aminoglycoside nucleotidyltransferase in Bacillus clausii. Antimicrob Agents Chemother. 2003; 47(5):1343–6. https://doi.org/10.1128/AAC.47.4.1343-1346.2003
  104. Danilevskaya NV. Farmakostimulyaciya produktivnosti zhivotnyh probioticheskimi preparatami: avtoref. dis. doktora vet. nauk. 16.00.04 - Veterinarnaya farmakologiya s toksikologiej. Moscow; 2007. Russian.
  105. Ezema C. Probiotics in animal production: A review. Journal of Veterinary Medicine and Animal Health. 2013; 5(11):308–16.
  106. Kyffin J. The Role of Probiotics in Veterinary Medicine. International Animal Health Journal – Research and Development. 2016; 3(1):46-9.
  107. Pavlov DS, Egorov IA, Nekrasov RV. Ispolzovanie biologicheski aktivnyh kormovyh dobavok dlya povysheniya pitatelnyh svojstv kombikormov i uvelicheniya norm vvoda v kombikorma shrotov i zhmyhov. Probl biologii produkt zhivotnyh. 2011; 1:89–92. Russian.
  108. Yirga H. The use of probiotics in animal nutrition. J Prob Health. 2015; 3:132. https://doi.org/10.4172/2329-8901.1000132
  109. Food and Agriculture Organization of the United Nations. FAO animal production and healh. Probiotics in Animal Nutrition. Rome. 2016:1–108.
  110. Ahasan ASML, Agazzi A, Invernizzi G, Bontempo V, Savoini G. The beneficial role of Probiotics in monogastric animal nutrition and health. J Dairy Vet Anim Res. 2015;2(4):116‒132. https://doi.org/10.15406/jdvar.2015.02.00041
  111. Probiole. Probiotiki. Enzim. https://enzim.biz/index.php?page=probiol&lng=ua
  112. Yuhimenko LN, Byichkova LI. Ispyitaniya lechebnogo kombikorma s subalinom v ryibhozah Moskovskoy oblasti. Ryibnoe hozyaystvo. 2012; 4:96–8.
  113. Šabatková J, Kumprecht I, Zobač P, Suchý P, Čermák B. The Probiotic BioPlus 2B as an Alternative to Antibiotics in Diets for Broiler Chickens. Acta Vet Brno 2008; 77:569–74. https://doi.org/10.2754/avb200877040569